XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (37,127,303) $ (53,478,812) $ (28,059,807)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 12,829 28,834 11,126
Stockbased compensation 7,813,743 4,983,023 1,345,722
Amortization of right of use lease asset 258,848 200,776 159,128
Foreign currency (gain) loss (317,402) 890,252 (1,328,140)
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (109,338) (472,402) (2,633,732)
Accounts payable (2,730,587) 2,326,767 437,515
Accrued expenses and other liabilities (5,218,241) 3,928,684 3,513,782
Lease liability (268,728) (209,794) (154,301)
Net cash used in operating activities (37,686,179) (41,802,672) (26,708,707)
Cash flows from investing activities:      
Purchases of property and equipment   (25,709) (30,901)
Net cash used in investing activities   (25,709) (30,901)
Cash flows from financing activities:      
Proceeds from the exercise of stock options 208,367 150,949 70,997
Proceeds from issuance of common stock in initial public offering, net     86,906,179
Proceeds from at-the-market sales of common stock, net 1,538,645    
Proceeds from issuance of Series C convertible preferred, net     5,598,362
Net cash provided by financing activities 1,747,012 150,949 92,575,538
Decrease in cash and cash equivalents (35,939,167) (41,677,432) 65,835,930
Effect of exchange rate changes on cash (2,467) 606,249 (1,422,992)
Cash and cash equivalents-beginning of year 89,017,686 130,088,869 65,675,931
Cash and cash equivalents-end of period 53,076,052 $ 89,017,686 $ 130,088,869
Non-cash investing and financing activities:      
Operating lease liabilities arising from obtaining right-of-use assets $ 124,043